Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRL757 in Healthy Volunteers
NCT06493045Phase 1Completed
- Sponsor
- IRLAB
- Start
- May 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in apathy comparing IRL757 with Placebo Comparator (2 arms). Primary endpoints: Adverse Events, Physical Examination Findings and 4 more. Started May 2024; status: completed.
02
Drugs
IRL757
03
Conditions
apathy
Beyond the preview
Go deeper on NCT06493045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06493045.